K

Kailera Therapeutics

Clinical-stage obesity and metabolic drugs developer

Director of Program Management

Program ManagementConfirmed live in the last 24 hours
Full-timeWaltham, MA, USA

About the Job

Requirements

  • Strong understanding of drug development and commercialization and how biotechnology functions integrate.
  • Experience managing cross-functional teams and complex projects, including required Phase 3 late-stage drug development experience.
  • Demonstrated experience and working knowledge across clinical development, commercial, regulatory, and technical operations/chemistry, manufacturing, and controls, and how these functions integrate across the drug development lifecycle.
  • Demonstrated project management and interpersonal skills.
  • Problem-solving, organizational, attention-to-detail, and analytical skills.
  • Ability to manage multiple priorities in a fast-paced, dynamic environment.
  • Ability to navigate ambiguity and drive clarity.
  • Ability to respond to changing priorities and uncertainty with composure, resilience, and an open mind.
  • Record of collaboration and communication skills.
  • Proficiency with project management tools such as Smartsheet, Microsoft Project, Excel, think-cell, and OnePager.
  • Experience in both pharmaceutical and biotechnology environments, including larger organizations and high-growth biotechnology companies.
  • A bachelor's degree in science, engineering, or a related field with at least 10 years of relevant experience, or an advanced degree with at least 8 years of project management experience in the biotechnology, pharmaceutical, or life sciences industry.

Responsibilities

  • Support the Program Leader with planning, execution, and delivery of multiple projects across asset development.
  • Collaborate with cross-functional teams, including Clinical, Regulatory, Non-clinical, and Technical Operations, to ensure alignment with company and program objectives.
  • Collaborate with the Program Leader to ensure agenda topics and outputs align with the program's overall strategic development plan.
  • Develop and own detailed integrated project plans, including goals, deliverables, timelines, and resource requirements.
  • Identify and manage project risks, issues, and dependencies, and proactively implement mitigation strategies.
  • Monitor project progress and provide regular updates to the Program Leader and stakeholders, ensuring clear communication and transparency.
  • Create and own program reports for executive and other governance teams.
  • Collaborate with cross-functional teams, including Clinical, Regulatory, Non-clinical, Technical Operations, and Commercial, to drive the overall program and other projects forward.
  • Oversee development and execution of project plans from initiation to completion, ensuring completion on time, in scope, and within budget.
  • Work closely with teams to identify potential risks and implement solutions.

Desired Qualifications

  • Experience in strategic planning for NDA filing, post-approval commitments, and U.S. commercialization.
  • Prior experience in general medicine therapeutic areas such as cardiovascular, diabetes, endocrinology, metabolic disease, or similar.
  • A master's degree in life sciences.
  • Project Management Professional certification.

About the Company

Kailera Therapeutics

Clinical-stage obesity and metabolic drugs developer

Kailera Therapeutics focuses on obesity and related metabolic conditions by acquiring and developing clinical-stage drug candidates and moving them toward commercialization. Its lead asset, KAI-9531, is an injectable dual agonist of GLP-1 and GIP receptors for obesity and type 2 diabetes, and the pipeline includes an oral GLP-1 agonist (KAI-7535), an oral tablet form of KAI-9531, and an injectable tri-agonist targeting GLP-1, GIP, and glucagon receptors (KAI-4729). The company differentiates itself by sourcing assets outside of early research, pursuing a mix of injectable and oral therapies, and leveraging a high-profile leadership team and substantial funding to progress a broad portfolio under external licenses. Kailera’s goal is to advance multiple metabolic disease therapies from clinical development toward commercialization to improve outcomes for patients with obesity and related conditions.

Company size
51-200
Company stage
IPO
Headquarters
Waltham, MA
Founded
2024

Recently Posted Jobs

Explore more opportunities at Kailera Therapeutics

See more jobs